Journal of Clinical & Experimental Dermatology Research · 2010 · 22 citations · 9 references
MedicineDermatologyImmunologyAutoimmunityDermatopathologyImmunopathologyAutoantibodiesAutoimmune Skin DiseasesImmunopathology Of SkinInflammatory DermatosesMucocutaneous DisordersOral Mucosal LesionsAnti-desmoglein AutoantibodiesAutoantibodies To Desmoglein 1Autoantibodies To Desmoglein 3Autoimmune Blistering DermatosesCutaneous BlisteringCutaneous ImmunologyDesmoglein AutoantibodiesDesmoglein Autoimmunity
Pemphigus vulgaris is a chronic autoimmune mucocutaneous disease characterized by the formation of intraepithelial blisters. It results from an autoimmune process in which antibodies are produced against desmoglein 1 and desmoglein 3, normal components of the cell membrane of keratinocytes. The first manifestations of pemphigus vulgaris appear in the oral mucosa in the majority of patients, followed at a later date by cutaneous lesions. The diagnosis is based on clinical findings and laboratory analyses, and it is usually treated by the combined administration of corticosteroids and immunosuppressants. Detection of the oral lesions can result in an earlier diagnosis. We review the oral manifestations of pemphigus vulgaris as well as the differential diagnosis, treatment, and prognosis of oral lesions in this uncommon disease.
9
Pemphigus vulgaris in oral cavity: clinical analysis of 71 cases.
Thorakkal Shamim, Vengal Ipe Varghese, P M Shameena et al. · PubMed · 2008 · 90 citations · Full text
Diya F. Mutasim, Nancy J. Pelc, Grant J. Anhalt · Dermatologic Clinics · 1993 · 50 citations
Pemphigus vulgaris: a case-based update.
Nadia Ben Lagha, Vincent Poulesquen, Jean‐Claude Roujeau et al. · PubMed · 2005 · 46 citations